A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

Session ID: 2025-06-24:936f947c98ce6f73831a607 Player Element ID: V3f69f3ef_05ce_43e7_acbe_c951afabbbb5_6374131301112 ...

HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug Administration ...

June 17, 2025 – The FDA has expanded the use of Moderna's respiratory syncytial virus (RSV) shot to all adults, with some limits on who can get it. First approved in 2024 for people 60 or older ...

HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug ...

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 15, 2025 / 09:03 AM CDT Updated: Jun 15, 2025 / 09:03 AM CDT ...

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 14, 2025 / 06:24 PM CDT Updated: Jun 14, 2025 / 06:24 PM CDT ...

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 13, 2025 / 09:32 PM EDT Updated: Jun 13, 2025 / 09:32 PM EDT ...